Fig. 7: Effects of deoxycytidine on IMR32 neuroblastoma cells treated with brequinar or with the brequinar+cytidine combination in medium supplemented with HS.

A–D IMR32 cells grown in medium supplemented with HS were treated with the indicated compounds or recombinant human CDA and their growth was monitored by the IncuCyte system. The data in panels B–D is from the same experiment.